Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Inhibition of PIM Kinases Targets Synthetic Vulnerabilities and Enhances Antigen Presentation in B-Cell Lymphoma

Patrizia Mondello, MD PhD MSc, Chiara Tarantelli, PhD, Luciano Cascione, PhD, Alberto Arribas, PhD, Andrea Rinaldi, Anas Younes, MD, Francesco Bertoni, MD

Blood (2019) 134 (Supplement_1): 2858.

https://doi.org/10.1182/blood-2019-125123

Published: 2019

Journal Articles

Targeting Polo-like Kinase 4 for Therapeutic Benefit in the Patients with Diffuse Large B-Cell Lymphoma

Yi Zhao, MM, Yang Han, MM, Juan Yang, MM, Shunfeng Hu, Xin Wang, MD PhD

Blood (2019) 134 (Supplement_1): 2568.

https://doi.org/10.1182/blood-2019-129548

Published: 2019

Journal Articles

A Standardized Equation Model of Quality of Life in Myeloproliferative Neoplasms

Robyn M. Scherber, MDMPH, Martin M. Goros, MS, Jonathan Gelfond, MD PhD, Amylou C. Dueck, PhD, Sarah F Christensen, MD, Hans Hasselbalch, MD, Holly L. Geyer, MD, Ruben A Mesa, MD

Blood (2019) 134 (Supplement_1): 2181.

https://doi.org/10.1182/blood-2019-126803

Published: 2019

Journal Articles

Validation of Instrument to Assess Hemophilia-Related Distress

Christine L. Kempton, MD MSc, Vaughn Barry, PhD MPH, Tyler W. Buckner, MD MSc, Janet Figueroa, MPH, Shanna Mattis, MPH, Mary Ellen Lynch, PhD, Mary E Stout, MD, Stephanie Whitten, Scott Gillespie, Courtney McCracken, PhD

Blood (2019) 134 (Supplement_1): 936.

https://doi.org/10.1182/blood-2019-122544

Published: 2019

Journal Articles

Pre-Transplant Genetic Susceptibility in Adult Allogeneic Hematopoietic Cell Transplant Recipients: Incidence and Clinical Relevance in Transplant-Associated Thrombotic Microangiopathy

Blood (2018) 132 (Supplement 1): 3401.

https://doi.org/10.1182/blood-2018-99-112041

Published: 2018

Journal Articles

Preclinical Validation Studies Support Causal Machine Learning Based Identification of Novel Drug Targets for High-Risk Multiple Myeloma

Arnold Bolomsky, Fred Gruber, PhD, Kathrin Stangelberger, MSc, Leon Furchtgott, PhD, Dominik Arnold, Puja Raut, Diane Wuest, PhD, Karl Runge, Iya Khalil, Niklas Zojer, MD, Nikhil Munshi, MD, Boris Hayete, PhD, Heinz Ludwig, MD

Blood (2018) 132 (Supplement 1): 3210.

https://doi.org/10.1182/blood-2018-99-117886

Published: 2018

Journal Articles

Complement-Mediated Thrombotic Microangiopathy: A Murky Presentation of a Rare Disease Entity

Patrick Fleming, MD, Maggie Cheung, MD, David Sokol, MD

Blood (2018) 132 (Supplement 1): 5005.

https://doi.org/10.1182/blood-2018-99-119893

Published: 2018

Journal Articles

Observations from the First 1,000 Suspected aHUS Patients, Tested By a Rapid aHUS Genetic (NGS) Panel: Causative Genes Identified in a Subpopulation of Our Database

James Anderson-Furgeson, PhD, Jamey Kain, PhD, Sujatha Venkataramani, PhD, Jooeun Lim, PhD, Mike Ero, MT, CLS, MBA, Bradley Lewis, MD

Blood (2018) 132 (Supplement 1): 5017.

https://doi.org/10.1182/blood-2018-99-120308

Published: 2018

Journal Articles

The Whole Exome Analysis and Clinical Relevance in Patients with Atypical Hemolytic Uremic Syndrome

Mustafa Nuri Yenerel, Yasar Caliskan, Alaattin Yildiz, Sedat Karadeniz, Aydin Turkmen, Mehmet Seit Kayacan, Tufan Tukek, Murat Köse, Melih Aktan, Meliha Nalcaci

Blood (2017) 130 (Supplement 1): 3618.

https://doi.org/10.1182/blood.V130.Suppl_1.3618.3618

Published: 2017

Journal Articles

Three Cases of Patients with Complement Regulatory Factor Genetic Mutations and Acquired Thrombotic Thrombocytopenic Purpura (TTP)

Shebli Atrash, MD, David Kent McKelvey, MD, Appalanaidu Sasapu, MD MS, Muthu Veeraputhiran, MD MPH, Soumya Pandey, MD, Michele H. Cottler-Fox, MD, Pooja Motwani, MD

Blood (2016) 128 (22): 1362.

https://doi.org/10.1182/blood.V128.22.1362.1362

Published: 2016

Journal Articles

Diagnosis and Outcomes of Patients Presenting with Microangiopathic Hemolytic Anemia and Thrombocytopenia to a University Hospital Apheresis Unit

Katerina Pavenski, BSc, MD FRCPC, Megan Buchholz, BScN, RN, Michelle Sholzberg, MDM, MSc

Blood (2016) 128 (22): 1366.

https://doi.org/10.1182/blood.V128.22.1366.1366

Published: 2016

Journal Articles

Modified Ham Test Distinguishes aHUS from TTP and Predicts Response to Eculizumab

Eleni Gavriilaki, MD, Xuan Yuan, MD MSc, Zhaohui Ye, PhD, Michael B. Streiff, MD, Thomas S Kickler, MD, Alison R Moliterno, MD, John Sperati, MD, Robert A. Brodsky, MD

Blood (2015) 126 (23): 103.

https://doi.org/10.1182/blood.V126.23.103.103

Published: 2015

Journal Articles

Novel Genetic Variants in Complement-Mediated Thrombotic Microangiopath

Blood (2015) 126 (23): 1050.

https://doi.org/10.1182/blood.V126.23.1050.1050

Published: 2015

Journal Articles

Complement Regulatory Gene Mutations in Non-Renal Solid Organ Transplant Recipients with Post-Transplant Thrombotic Microangiopathy

Kruti Sheth, MD, Raffaele Girlanda, MD, Catherine Broome, MD

Blood (2015) 126 (23): 3463.

https://doi.org/10.1182/blood.V126.23.3463.3463

Published: 2015

Journal Articles

Chronic Glomerulonephritis Causing Atypical Hemolytic Uremic Syndrome

Waqas Jehangir, MBBS, MD

Blood (2014) 124 (21): 5027.

https://doi.org/10.1182/blood.V124.21.5027.5027

Published: 2014

Journal Articles

Pregnancy-Associated Atypical Hemolytic Uremic Syndrome (aHUS), Treated with Eculizumab

Eudokia M. Mandala, Associate Professor, Spyridon Gkiouzepas, MD, Efstratios Kasimatis, MD, Christos Lafaras, MD PhD, Parthenis Chalevas, MD, Konstantina Tsioni, MD PhD, Krystallia Kyrka, MD, Dominiki Oikonomidou, MD PhD, Konstantinos Dinas, Assistant Professor, Aristotelis Loufopoulos, Professor, George Efstratiadis, Professor, Garipidou Vasilia, Professor, Anastasios-Alexandros Garyfallos, Professor

Blood (2014) 124 (21): 5019.

https://doi.org/10.1182/blood.V124.21.5019.5019

Published: 2014

Journal Articles

Utility of Complement and ADAMTS13 Testing in Diagnosis of Thrombotic Microangiopathy: A Single Centre Retrospective Review

Katerina Pavenski, MD FRCP, Christoph Licht, MD, Michael Kirschfink

Blood (2014) 124 (21): 2787.

https://doi.org/10.1182/blood.V124.21.2787.2787

Published: 2014

Journal Articles

Genotype Phenotype Correlation in Patients with aHUS and Abnormal Genetic Studies: A Single Centre Experience

Katerina Pavenski, MD FRCP, Jerome M. Teitel, MD, Gloria Lim, BSc, MSc, MD, Michelle Sholzberg, MD, Michael Kirschfink, Christoph Licht, MD FRCP(C), FASN

Blood (2014) 124 (21): 4186.

https://doi.org/10.1182/blood.V124.21.4186.4186

Published: 2014

Journal Articles

Atypical Hemolytic Uremic Syndrome In Japan Characterized By The Inhibitory Antibody-Based Hemolytic Assay and The Gene Analysis

Yoko Yoshida, MS, Xinping Fan, MD, Yoshifumi Ohyama, PhD, Tetsuro Kokubo, PhD, Masanori Matsumoto, MD, PhD, Hideo Yagi, MD, PhD, Hiroko Shirotani-Ikejima, PhD, Toshiyuki Miyata, PhD, Yoshihiro Fujimura, MD, PhD

Blood (2013) 122 (21): 2318.

https://doi.org/10.1182/blood.V122.21.2318.2318

Published: 2013

Journal Articles

Identification Of aHUS and Complement Mutations In Patients Presenting With Acute Thrombotic Microangiopathy

Elizabeth H Phillips, MD, John Connolly, MD, John-Paul Westwood, MD, Siobhan McGuckin, Daniel P Gale, MD, Tim H. J. Goodship, MD, David Kavanagh, MD, Marie A Scully, MD

Blood (2013) 122 (21): 1073.

https://doi.org/10.1182/blood.V122.21.1073.1073

Published: 2013

NARROW

Inhibition of PIM Kinases Targets Synthetic Vulnerabilities and Enhances Antigen Presentation in B-Cell Lymphoma

Targeting Polo-like Kinase 4 for Therapeutic Benefit in the Patients with Diffuse Large B-Cell Lymphoma

A Standardized Equation Model of Quality of Life in Myeloproliferative Neoplasms

Validation of Instrument to Assess Hemophilia-Related Distress

Pre-Transplant Genetic Susceptibility in Adult Allogeneic Hematopoietic Cell Transplant Recipients: Incidence and Clinical Relevance in Transplant-Associated Thrombotic Microangiopathy

Preclinical Validation Studies Support Causal Machine Learning Based Identification of Novel Drug Targets for High-Risk Multiple Myeloma

Complement-Mediated Thrombotic Microangiopathy: A Murky Presentation of a Rare Disease Entity

Observations from the First 1,000 Suspected aHUS Patients, Tested By a Rapid aHUS Genetic (NGS) Panel: Causative Genes Identified in a Subpopulation of Our Database

The Whole Exome Analysis and Clinical Relevance in Patients with Atypical Hemolytic Uremic Syndrome

Three Cases of Patients with Complement Regulatory Factor Genetic Mutations and Acquired Thrombotic Thrombocytopenic Purpura (TTP)

Diagnosis and Outcomes of Patients Presenting with Microangiopathic Hemolytic Anemia and Thrombocytopenia to a University Hospital Apheresis Unit

Modified Ham Test Distinguishes aHUS from TTP and Predicts Response to Eculizumab

Novel Genetic Variants in Complement-Mediated Thrombotic Microangiopath

Complement Regulatory Gene Mutations in Non-Renal Solid Organ Transplant Recipients with Post-Transplant Thrombotic Microangiopathy

Chronic Glomerulonephritis Causing Atypical Hemolytic Uremic Syndrome

Pregnancy-Associated Atypical Hemolytic Uremic Syndrome (aHUS), Treated with Eculizumab

Utility of Complement and ADAMTS13 Testing in Diagnosis of Thrombotic Microangiopathy: A Single Centre Retrospective Review

Genotype Phenotype Correlation in Patients with aHUS and Abnormal Genetic Studies: A Single Centre Experience

Atypical Hemolytic Uremic Syndrome In Japan Characterized By The Inhibitory Antibody-Based Hemolytic Assay and The Gene Analysis

Identification Of aHUS and Complement Mutations In Patients Presenting With Acute Thrombotic Microangiopathy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only